Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 128Colonic Neoplasms 54Rectal Neoplasms 49Carcinoma, Hepatocellular 29Stomach Neoplasms 23Neoplasm Metastasis 20Pancreatic Neoplasms 10Cholangiocarcinoma 9Neoplasms 8Adenocarcinoma Of Esophagus 8Esophageal Neoplasms 7Liver Neoplasms 6Gastrointestinal Neoplasms 5Biliary Tract Neoplasms 5Recurrence 4Ovarian Neoplasms 3Esophageal Squamous Cell Carcinoma 3Digestive System Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Unresectable Metastatic Colorectal Cancer 2Neurotoxicity Syndromes 2Neoplastic Cells, Circulating 2Intestinal Neoplasms 2Gastrointestinal Diseases 2Gallbladder Neoplasms 2Colorectal Cancer Metastatic 2Cirrhosis, Familial, with Pulmonary Hypertension 2Breast Neoplasms 2Adenocarcinoma 2Squamous Cell Carcinoma of Head and Neck 1

Interventions

irinotecan sucrosofate 1Folfox protocol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Locally Advanced Pancreatic Carcinoma(LAPC) × Folfox protocol × Gastrointestinal × Clear all
NCT03861702 2025-04-18

Liposomal Irinotecan in Combination With Oxaliplatin, Leucovorin, and 5-fluorouracil for Patients With Locally Advanced Pancreatic Carcinoma:

Big Ten Cancer Research Consortium

Phase 2 Completed
28 enrolled 20 charts
Gastrointestinal

Locally Advanced Pancreatic Carcinoma(LAPC)

Data powered by HemOnc (CC BY 4.0) Colophon âš¡